Arthritis, Psoriatic — Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
Citation(s)
Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Adult-Onset Active and Progressive Psoriatic Arthritis (PsA)